News

Argenica Therapeutics Ltd ( ($AU:AGN) ) has shared an announcement. Argenica Therapeutics has encountered a clinical hold from the US FDA on its ...
Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has issued an update. Botanix Pharmaceuticals has secured a debt facility of approximately A$48 ...
Vaccines stocks slipped late Monday after HHS fired all members of a CDC committee in charge of making vaccine suggestions.
IMUX stock's drop appears to be an overreaction, given positive disability progression data and clean safety profile. Click ...
Phathom Pharmaceuticals, Inc. has secured 10 years of FDA exclusivity for Voquezna in GERD, boosting its stock. Click here to ...
Aethlon Medical's Hemopurifier® is an investigational extracorporeal device designed to bind and remove harmful EVs from the ...
Opinion
Zacks Investment Research on MSN14hOpinion
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...
Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first quarter 2025 investor ...
Shares of Axsome Therapeutics, Inc. (AXSM) slumped 3% in the pre-market session on Monday after the company said that it has ...
Humacyte markets Symvess for the treatment of extremity vascular trauma. Read why HUMA stock is a Sell but can see its ...